Abstract
Animal models of renal disease are essential tools in research on kidney disease and have provided valuable insights into pathogenesis. Use of animal models minimises inter-individual differences, allows specific pathological changes to be examined, and facilitates collection of tissue samples. Thus, mechanistic research and identification of biomarkers are possible. Various animal models manifesting specific pathological lesions can be used to investigate acute or chronic kidney disease (CKD). Urine, a terminal metabolic product, is produced via glomerular filtration, reabsorption, and excretion in the tubular and collecting ducts, reflecting the functions of glomeruli or tubular tissue stimulated in various ways or subject to disease. Almost 70 % of urinary proteins originate from the kidney (the other 30 % come from plasma), and urinary sampling is important to noninvasively detect renal disease. Proteomics is powerful when used to screen urine components. Increasingly, urine proteomics is used to explore the pathogenesis of kidney disease in animals and to identify novel biomarkers of renal disease. In this section, we will introduce the field of urinary proteomics as applied in different models of animal renal disease and the valuable role played by proteomics in noninvasive diagnosis and rational treatment of human renal disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akimau P, Yoshiya K, Hosotsubo H, Takakuwa T, Tanaka H, Sugimoto H (2005) New experimental model of crush injury of the hindlimbs in rats. J Trauma 58:51–58
Antoine DJ, Srivastava A, Pirmohamed M, Park BK (2010) Statins inhibit aminoglycoside accumulation and cytotoxicity to renal proximal tubule cells. Biochem Pharmacol 79:647–654
Blachar Y, Fong JS, de Chadarevian JP, Drummond KN (1981) Muscle extract infusion in rabbits. A new experimental model of the crush syndrome. Circ Res 49:114–124
Borza DB, Hudson BG (2003) Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease. In: Springer seminars in immunopathology, vol 24. Springer, Berlin, pp 345–361
Cui Z, Zhao MH (2011) Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol 7:697–705
Debelle FD, Nortier JL, De Prez EG, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem JL (2002) Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13:431–436
Gerth JH, Kriegsmann J, Trinh TT, Stahl RA, Wendt T, Sommer M, Stein G, Wolf G (2002) Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int 61:68–79
Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 279:F130–F143
Jefferson JA, Johnson RJ (1999) Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 12:297–307
Jefferson JA, Pippin JW, Shankland SJ (2010) Experimental models of membranous nephropathy. Drug Discov Today Dis Models 7:27–33
Kim MG, Koo TY, Yan JJ, Lee E, Han KH, Jeong JC, Ro H, Kim BS, Jo SK, Oh KH, Surh CD, Ahn C, Yang J (2013) IL-2/Anti-IL-2 complex attenuates renal ischemia-reperfusion injury through expansion of regulatory T cells. J Am Soc Nephrol 24:1529–1536
Lu Y, Liu X, Shi S, Su H, Bai X, Cai G, Yang F, Xie Z, Zhu Y, Zhang Y, Zhang S, Li X, Wang S, Wu D, Zhang L, Wu J, Xie Y, Chen X (2012) Bioinformatics analysis of proteomic profiles during the process of anti-thy1 nephritis. Mol Cell Proteomics 11:M111–008755
Maddens B, Ghesquiere B, Vanholder R, Demon D, Vanmassenhove J, Gevaert K, Meyer E (2012) Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury. Mol Cell Proteomics 11:M111–013094
Moreno S, Ibraghimov-Beskrovnaya O, Bukanov NO (2008) Serum and urinary biomarker signatures for rapid preclinical in vivo assessment of CDK inhibition as a therapeutic approach for PKD. Cell Cycle 7:1856–1864
Murata I, Ooi K, Sasaki H, Kimura S, Ohtake K, Ueda H, Uchida H, Yasui N, Tsutsui Y, Yoshizawa N, Hirotsu I, Morimoto Y, Kobayashi J (2011) Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model. J Trauma 70:1453–1463
Nabity MB, Lees GE, Dangott LJ, Cianciolo R, Suchodolski JS, Steiner JM (2011) Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease. Vet Clin Pathol 40:222–236
Reynolds J (2011) Strain differences and the genetic basis of experimental autoimmune anti-glomerular basement membrane glomerulonephritis. Int J Exp Pathol 92:211–217
Rouse R, Siwy J, Mullen W, Mischak H, Metzger J, Hanig J (2012) Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat. PLoS ONE 7:e34606
Rouse RL, Zhang J, Stewart SR, Rosenzweig BA, Espandiari P, Sadrieh NK (2011) Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney Int 79:1186–1197
Rucevic M, Rosenquist T, Breen L, Cao L, Clifton J, Hixson D, Josic D (2012) Proteome alterations in response to aristolochic acids in experimental animal model. J Proteomics 76:79–90
Shihab FS, Bennett WM, Tanner AM, Andoh TF (1997) Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660–673
Taal MW, Zandi-Nejad K, Weening B, Shahsafaei A, Kato S, Lee KW, Ziai F, Jiang T, Brenner BM, MacKenzie HS (2000) Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 58:1664–1676
Thongboonkerd V, Klein JB, Pierce WM, Jevans AW, Arthur JM (2003) Sodium loading changes urinary protein excretion: a proteomic analysis. Am J Physiol Renal Physiol 284:F1155–F1163
Throssell D, Brown J, Furness PN, Rutty G, Walls J, Harris KP (1997) D-penicillamine reduces renal injury in the remnant model of chronic renal failure in the rat. Nephrol Dial Transplant 12:1116–1121
Wang Y, Kramer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H (2005) Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Kidney Int 68:47–61
Wang YD, Zhang L, Cai GY, Zhang XG, Lv Y, Hong Q, Shi SZ, Yin Z, Liu XF, Chen XM (2011) Fasudil ameliorates rhabdomyolysis-induced acute kidney injury via inhibition of apoptosis. Ren Fail 33:811–818
Wu L, Feng Z, Cui S, Hou K, Tang L, Zhou J, Cai G, Xie Y, Hong Q, Fu B, Chen X (2013) Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury. PLoS ONE 8:e63799
Wu T, Xie C, Bhaskarabhatla M, Yan M, Leone A, Chen SS, Zhou XJ, Putterman C, Mohan C (2007) Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum 56:949–959
Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, Hu X, Chawla L, Shen RF, Knepper MA, Star RA (2006) Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 70:1847–1857
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lv, Y., Cai, G., Chen, X. (2015). Applications of Urinary Proteomics in Renal Disease Research Using Animal Models. In: Gao, Y. (eds) Urine Proteomics in Kidney Disease Biomarker Discovery. Advances in Experimental Medicine and Biology, vol 845. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9523-4_14
Download citation
DOI: https://doi.org/10.1007/978-94-017-9523-4_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9522-7
Online ISBN: 978-94-017-9523-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)